Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults-Reference-Cited by-同舟云学术

Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults

Published:2024-01 Issue:2 Volume:42 Page:295-309
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Jackson Lisa A.^ORCID,Stapleton Jack T.^ORCID,Walter Emmanuel B.,Chen Wilbur H.^ORCID,Rouphael Nadine G.^ORCID,Anderson Evan J.^ORCID,Neuzil Kathleen M.^ORCID,Winokur Patricia L.,Smith Michael J.,Schmader Kenneth E.,Swamy Geeta K.^ORCID,Thompson Amelia B.,Mulligan Mark J.,Rostad Christina A.,Cross Kaitlyn,Tsong Rachel^ORCID,Wegel Ashley^ORCID,Roberts Paul C.^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference31 articles.

1. Human infection with a novel avian-origin influenza A (H7N9) virus;Gao;N Engl J Med,2013

2. Epidemiology of human infections with avian influenza A(H7N9) virus in China;Li;N Engl J Med,2014

3. Update: Increase in human infections with novel asian lineage avian influenza A(H7N9) viruses during the fifth epidemic - China, October 1, 2016-August 7, 2017;Kile;MMWR Morb Mortal Wkly Rep,2017

4. Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013–17: an epidemiological study of laboratory-confirmed case series;Wang;Lancet Infect Dis,2017

5. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation;Qi;BMJ,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Computationally Optimized Broadly Reactive Hemagglutinin and Neuraminidase Vaccine Boosts Antibody-Secreting Cells and Induces a Robust Serological Response, Preventing Lung Damage in a Pre-Immune Model;Vaccines;2024-06-24